These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2783013)
1. [Stereospecific hydroxylation of (+)-sparteine (pachycarpine) in the rat]. Ebner T; Eichelbaum M; Fischer P; Meese CO Arch Pharm (Weinheim); 1989 Jul; 322(7):399-403. PubMed ID: 2783013 [TBL] [Abstract][Full Text] [Related]
2. Regioselectivity and stereoselectivity of the metabolism of the chiral quinolizidine alkaloids sparteine and pachycarpine in the rat. Ebner T; Meese CO; Eichelbaum M Xenobiotica; 1991 Jul; 21(7):847-57. PubMed ID: 1776260 [TBL] [Abstract][Full Text] [Related]
3. 2-Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine. Back DJ; Maggs JL; Purba HS; Newby S; Park BK Br J Clin Pharmacol; 1984 Oct; 18(4):603-7. PubMed ID: 6487500 [TBL] [Abstract][Full Text] [Related]
4. New mammalian metabolites of sparteine. Chaudhuri A; Keller WJ Life Sci; 1990; 47(4):319-25. PubMed ID: 2388532 [TBL] [Abstract][Full Text] [Related]
5. Spectral binding studies of the polymorphically metabolized drugs debrisoquine, sparteine and phenformin by cytochrome P-450 of normal and hydroxylation deficient rat strains. Küpfer A; Al-Dabbagh SG; Ritchie JC; Idle JR; Smith RL Biochem Pharmacol; 1982 Oct; 31(20):3193-9. PubMed ID: 7150348 [TBL] [Abstract][Full Text] [Related]
6. Benzo(a)pyrene metabolism in hepatic microsomes from female DA rats with a genetic sparteine oxidation deficiency. Schlede E; Roots I Toxicol Lett; 1985 Dec; 29(1):5-10. PubMed ID: 4082205 [TBL] [Abstract][Full Text] [Related]
7. The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphism. Ebner T; Eichelbaum M Br J Clin Pharmacol; 1993 Apr; 35(4):426-30. PubMed ID: 8485023 [TBL] [Abstract][Full Text] [Related]
8. A nuclear magnetic resonance study of sparteine delta metabolite structure. Ebner T; Meese CO; Fischer P; Eichelbaum M Drug Metab Dispos; 1991; 19(5):955-9. PubMed ID: 1686242 [TBL] [Abstract][Full Text] [Related]
9. Deficient metabolism of debrisoquine and sparteine. Inaba T; Otton SV; Kalow W Clin Pharmacol Ther; 1980 Apr; 27(4):547-9. PubMed ID: 7357813 [TBL] [Abstract][Full Text] [Related]
10. Stereo- and regioselectivity of hepatic oxidation in man--effect of the debrisoquine/sparteine phenotype on bufuralol hydroxylation. Dayer P; Leemann T; Küpfer A; Kronbach T; Meyer UA Eur J Clin Pharmacol; 1986; 31(3):313-8. PubMed ID: 2878813 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine. Bertilsson L; Dengler HJ; Eichelbaum M; Schulz HU Eur J Clin Pharmacol; 1980 Feb; 17(2):153-5. PubMed ID: 7371707 [TBL] [Abstract][Full Text] [Related]
12. Resolution of alkaloid racemate: a novel microbial approach for the production of enantiopure lupanine via industrial wastewater valorization. Parmaki S; Tsipa A; Vasquez MI; Gonçalves JMJ; Hadjiadamou I; Ferreira FC; Afonso CAM; Drouza C; Koutinas M Microb Cell Fact; 2020 Mar; 19(1):67. PubMed ID: 32169079 [TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry of bis-quinolizidine alkaloids: 2- and 17-alkyl-substituted derivatives of sparteine and lupanine. Wyrzykiewicz E; Boczoń W; Koziol B J Mass Spectrom; 2000 Nov; 35(11):1271-7. PubMed ID: 11114084 [TBL] [Abstract][Full Text] [Related]
15. A comparative study of the effects of sparteine, lupanine and lupin extract on the central nervous system of the mouse. Pothier J; Cheav SL; Galand N; Dormeau C; Viel C J Pharm Pharmacol; 1998 Aug; 50(8):949-54. PubMed ID: 9751462 [TBL] [Abstract][Full Text] [Related]
16. The relationship between the acetylator and the sparteine hydroxylation polymorphisms. Harmer D; Evans DA; Eze LC; Jolly M; Whibley EJ J Med Genet; 1986 Apr; 23(2):155-6. PubMed ID: 3712391 [TBL] [Abstract][Full Text] [Related]
17. [The mechanism of action of pachycarpine on the nicotinic cholinoreceptors of sympathetic ganglion neurons in the rat]. Purnyn' SL; Voĭtenko SV Neirofiziologiia; 1989; 21(5):701-4. PubMed ID: 2601769 [TBL] [Abstract][Full Text] [Related]
19. Sparteine metabolism capacity in human liver: structural variants of human P450IID6 as assessed by immunochemistry. Tyndale RF; Gonzalez FJ; Hardwick JP; Kalow W; Inaba T Pharmacol Toxicol; 1990 Jul; 67(1):14-8. PubMed ID: 2395811 [TBL] [Abstract][Full Text] [Related]
20. Gas chromatography/mass spectrometry assays for the determination of debrisoquine and sparteine metabolites in microsomal fractions of rat liver. Ho JW; Moody DE Anal Biochem; 1992 Jun; 203(2):348-51. PubMed ID: 1416032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]